Connecting the Dots - Part 1: Does the New WASF3 Brain Study Hold the Key to Older ME/CFS Data?

The recent groundbreaking study on WASF3 in the brain, combined with previous research linking the same protein to muscle fatigue and exercise intolerance, marks a potential paradigm shift in how we view Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Finding the exact same molecular bottleneck in two completely distinct types of tissue—muscles and the brain—strongly suggests that we are not looking at an isolated organ issue, but rather a systemic cellular malfunction. This realization invites an exciting and necessary question: If this WASF3 stress-and-energy trap is truly a universal cellular feature of ME/CFS, can we find its biochemical fingerprints hidden in plain sight within older, independent datasets? By revisiting previous transcriptomic studies through this new molecular lens, we might just find that different research teams have been looking at different pieces of the exact same puzzle.

A Curious Look at the Immune System: The IER3 and MAM Connection

When we look at past ME/CFS research, one study particularly stands out. A 2019 transcriptomic analysis of circulating immune cells (PBMCs) by a New Zealand cohort led by Warren Sweetman mapped out altered gene expressions in patients. Interestingly, WASF3 itself does not typically show up as significantly altered in blood tests, as it is primarily expressed in muscle and brain tissue. However, when we analyze the top altered genes from that 2019 study, the entire cellular environment appears to reflect the exact downstream aftermath of the WASF3 pathway.

Most notably, the gene IER3 (also known as IEX-1) was found to be upregulated twofold in the patients' immune cells. In the new WASF3 brain model, elevated WASF3 triggers a stress cascade that activates IER3, which subsequently acts as a brake on mitochondrial energy production. Finding IER3 running in high gear inside the immune cells could hypothetically mean that the very same metabolic trap identified in the brain and muscles is also active in the immune system.

But the puzzle goes even deeper. The authors of the new brain study emphasized that we need to look closely at MAMs (Mitochondria-Associated Membranes). MAMs are the physical contact zones—the cellular interfaces—where the Endoplasmic Reticulum (ER) and the mitochondria communicate. The new study revealed that WASF3 localizes precisely at these MAM bridges, disrupting the delicate signaling required for normal cellular and neuronal function.

Remarkably, the rest of the 2019 gene table reads like a textbook response to a crisis unfolding at exactly this ER-mitochondria junction:

• The ER-Stress Signal: We see significant upregulation of PPP1R15A (a classic marker of ER stress) and G3BP2 (involved in forming cellular "stress granules" during a crisis). This signals that the ER side of the MAM bridge is under intense pressure.
• The Mitochondrial Counter-Response: At the same time, the immune cells show an increase in PMPCB (involved in processing mitochondrial proteins) and NAMPT (the master regulator of NAD+ salvage). This suggests the mitochondrial side of the bridge is desperately trying to adapt, rebuild its machinery, and keep making ATP (energy) despite the blockade.

While we cannot say anything with absolute certainty, it is highly compelling to hypothesize that ME/CFS immune cells are suffering from a localized crisis at the MAM interfaces, trapped in a state of chronic ER stress and mitochondrial suppression. Re-evaluating older data through the lens of these physical cellular bridges doesn't just validate past findings—it potentially weaves them together into a unified, systemic explanation for ME/CFS.

References:

Reference for PPP1R15A (GADD34) as an ER Stress Marker

• What it is: PPP1R15A encodes the protein GADD34 (Growth Arrest and DNA Damage-Inducible Protein). It is activated as a direct consequence of the Integrated Stress Response (ISR) and the Unfolded Protein Response (UPR) during periods of cellular ER stress. Its primary function is to help the cell resume normal protein production (via dephosphorylation of eIF2α) once a stress crisis begins to clear.
• Official Databases: You can link directly to the official NCBI Gene Result for PPP1R15A or the overview on Wikipedia: PPP1R15A.

Reference for G3BP2 as a Stress Granule Factor

• What it is: G3BP2 (G3BP Stress Granule Assembly Factor 2) encodes an essential scaffolding protein. When a cell is exposed to overwhelming stress—such as ER stress or oxidative stress—this protein binds to untranslated mRNA. It triggers a physical process called liquid-liquid phase separation (LLPS) to form stress granules, which act as membrane-less emergency depots protecting the cell's genetic messages during a crisis.

Syed AM, Ma J, Wang PY, Son Y, Penjweini R, Mattu N, Knutson JR, Nakamori-Yamashita S, Springer DA, Ganguly A, Liu C, Hwang PM. Stress-inducible WASF3 regulates brain metabolism and cognitive function. Proc Natl Acad Sci U S A. 2026 Nov 3;123(44):e2617198123. doi: 10.1073/pnas.2617198123. Epub 2026 Oct 27. PMID: 42945241; PMCID: PMC13732061. https://pubmed.ncbi.nlm.nih.gov/42945241/

Wang PY, Ma J, Kim YC, Son AY, Syed AM, Liu C, Mori MP, Huffstutler RD, Stolinski JL, Talagala SL, Kang JG, Walitt BT, Nath A, Hwang PM. WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci U S A. 2023 Aug 22;120(34):e2302738120. doi: 10.1073/pnas.2302738120. Epub 2023 Aug 14. PMID: 37579159; PMCID: PMC10450651. https://pubmed.ncbi.nlm.nih.gov/37579159/

Sweetman E, Ryan M, Edgar C, MacKay A, Vallings R, Tate W. Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis/chronic fatigue syndrome. Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738418820402. doi: 10.1177/2058738418820402. PMID: 30791746; PMCID: PMC6350121. https://pubmed.ncbi.nlm.nih.gov/30791746/